Why Strategy Matters in PCI

SELUTION SLR PTCA Drug-Eluting Balloon in DeNovo Lesions

SELUTION DeNovo Trial Flyer SELUTION4ISR Trial Flyer TCT SELUTION DeNovo Presentation

SELUTION SLR PTCA DEB Product Technology

Request a product Trial

Proprietary Phospholipid Coating

Proprietary Phospholipid Coating facilitates drug uptake and retention, in the tissue, with a minimal drug loss during the procedure while providing excellent deliverability.

  • Phospholipid blend containing and protecting MicroReservoirs at 1 ug/mm2 Sirolimus Dose*
  • Enhanced drug transfer efficiency

*Cordis 2024 Data on File.

MicroReservoirs

MicroReservoirs achieve a consistent and predictable drug release, at a therapeutic level, comparable to the latest generation drug-eluting stent technology

  • ~4 um spheres of Sirolimus mixed with biodegradeable polymer
  • Sustained drug release

SELUTION DeNovo Trial & Results